Upgrade to SI Premium - Free Trial

Verona Pharma plc (VRNA) Misses Q4 EPS by 3c

March 7, 2023 6:22 AM

Verona Pharma plc (NASDAQ: VRNA) reported Q4 EPS of ($0.02), $0.03 worse than the analyst estimate of $0.01.

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

Categories

Earnings